News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Paolo Tarantino: The highly debated results of PALOMA2 now published on JCO
Photo from Paolo Tarantino/X
Jan 29, 2024, 10:53

Paolo Tarantino: The highly debated results of PALOMA2 now published on JCO

Paolo Tarantino, Medical Oncologist, PhD Università degli Studi di Milano, Research Dana-Farber Cancer Institute, Harvard University, shared a post on X/Twitter:

“The highly debated results of PALOMA2 now published on JCO: the addition of palbociclib to 1L letrozole did not improve OS in HR+ MBC. The reason for the discrepancy with ribociclib and  abemaciclib data remains unclear. Ultimately led to a reduction in the use of palbociclib.”

View additional information.
Source: Paolo Tarantino/X

Abemaciclib cancer HR+ metastatic breast cancer JCO letrozole OncoDaily Oncology palbociclib PALOMA2 trial Paolo Tarantino Ribociclib
Special Coverage
Blog
Apr 22, 2025, 09:40
Devika Das: The HER2 diagnostic and treatment landscape in NSCLC
Blog
Apr 22, 2025, 09:32
Nwamaka Lasebikan: Redefining Research Leadership in Africa with SINCCAR
Blog
Apr 22, 2025, 09:19
Wafik S. El-Deiry: Our enemy is cancer that affects all of us in some way
Science
Apr 22, 2025, 09:14
Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski
Oncolibrary
Apr 22, 2025, 09:05
Why Does Chemotherapy Cause Hair Loss?
Blog
Apr 22, 2025, 09:03
Key sessions you can’t miss at ESTRO25
Blog
Apr 22, 2025, 09:03
High-level results from the DESTINY-Breast09 Phase III trial for patients living with HER2+ mBC - AstraZeneca
Blog
Apr 22, 2025, 08:41
Sumanta K. Pal: Hoping to see you all in this Peer View forum to discuss all the latest developments in kidney cancer therapy
Blog
Apr 22, 2025, 08:36
Sumanta Pal: Honored to sit down with Betty Ferrell, a pioneer in quality of life and palliative care research
Science
Apr 22, 2025, 07:55
Melvin LK Chua: 1st part of Radiotherapy Series that deep dives into PORT for Head Neck cancer
Blog
Apr 22, 2025, 07:30
Gevorg Tamamyan: Have you already nominated yourself or your colleague for the Yvonne Award 2025?
Blog
Apr 22, 2025, 07:08
Cecilia Monge B.: I am thrilled to join Johnson and Johnson Innovative Medicine as Medical Director